BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4855735)

  • 21. Immunological evaluation in patients with urological cancers.
    Martinez-Piñeiro JA; Muntanola P; Hidalgo L
    Eur Urol; 1977; 3(3):159-62. PubMed ID: 560302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
    Rost A; Kneppenberg U; Rost P
    Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune evaluation with skin testing. A study of testicular, prostatic, and bladder neoplasms.
    Schellhammer PF; Bracken RB; Bean MA; Pinsky CM; Whitmore WF
    Cancer; 1976 Jul; 38(1):149-56. PubMed ID: 947511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irradiation and/or surgery. Some areas of confrontation in urologic oncology.
    Whitmore WF
    Am J Clin Oncol; 1984 Dec; 7(6):595-606. PubMed ID: 6099052
    [No Abstract]   [Full Text] [Related]  

  • 25. Plenary lecture: lymphocytic infiltration in relationship to urologic tumors.
    Mostofi FK; Sesterhenn I
    Natl Cancer Inst Monogr; 1978 Dec; (49):133-41. PubMed ID: 571042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant therapy for genitourinary cancer.
    Messing E; deKernion JB
    Surg Clin North Am; 1981 Dec; 61(6):1331-46. PubMed ID: 7198295
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunotherapy in genitourinary neoplasia.
    Droller MJ
    J Urol; 1985 Jan; 133(1):1-5. PubMed ID: 2578065
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro cytotoxicity studies in bladder and renal cell cancer.
    Elhilali MM; Nayak SK
    Urology; 1976 May; 7(5):488-91. PubMed ID: 1274005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic competence in patients with urologic cancer.
    McLaughlin AP; Kessler WO; Triman K; Gittes RF
    J Urol; 1974 Feb; 111(2):233-7. PubMed ID: 4272638
    [No Abstract]   [Full Text] [Related]  

  • 30. Defective monocyte function in patients with genitourinary carcinoma.
    Hausman MS; Brosman S; Snyderman R; Mickey MR; Fahey J
    J Natl Cancer Inst; 1975 Nov; 55(5):1047-54. PubMed ID: 1107568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
    Hakala TR
    Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinoembryonic antigen in patients with urologic cancers.
    Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
    Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum induced lymphoid cell mediated cytotoxicity to human transitional cell carcinomas of the genitourinary tract.
    Hakala TR; Lange PH
    Science; 1974 May; 184(4138):795-7. PubMed ID: 4856602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response in bladder cancer.
    Merrin C; Han T
    J Urol; 1974 Feb; 111(2):170-2. PubMed ID: 4810757
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell-mediated cytotoxicity against human bladder cancer.
    Bloom ET; Ossorio RC; Brosman SA
    Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
    [No Abstract]   [Full Text] [Related]  

  • 36. [Value of alpha-globulin as a biological tracer in urogenital cancer].
    Gastón de Iriarte E; López-García JA; Hidalgo L; Mendoza M; Martínez-Piñeiro JA
    Actas Urol Esp; 1978; 2(3):119-26. PubMed ID: 79304
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunologic reduction of bladder cancer recurrence rate.
    Olsson CA; Chute R; Rao CN
    J Urol; 1974 Feb; 111(2):173-6. PubMed ID: 4810758
    [No Abstract]   [Full Text] [Related]  

  • 38. Cellular immunity in bladder cancer patients.
    Guinan P; McKiel C; Flanagan M; Bhatti R; Pessis D; Ablin RJ
    J Urol; 1978 Jun; 119(6):747-9. PubMed ID: 660759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective monocyte chemotactic response in genitourinary carcinoma.
    Brosman S; Hausman MS
    Urology; 1974 Aug; 4(2):129-34. PubMed ID: 4851277
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.